Smith Jeffrey T L
Officer at ZYME; Managing Director at ALDER BIOPHARMACEUTICALS INC
- Sold, on record
- $7.6M
- Dollars the filings state
- Form 4 sales
- 32
- Latest Jan 12, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- ZYMEZymeworks Inc.Officer
- ALDER BIOPHARMACEUTICALS INCManaging Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- ALDER BIOPHARMACEUTICALS INC260,270 shares
- ZYME30,958 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale ALDER BIOPHARMACEUTICALS INCUnusualDec 3, 2018 2018
Sold 5,044 shares at $13.84 ($70k)
Smith Jeffrey T L, Managing Director
Sold 85.9% of holdings ($81k position)831 shares left1x usual sizeFiling
- 2 Form 4 sale ALDER BIOPHARMACEUTICALS INCUnusualSep 16, 2019 +287 days
Sold 32,728 shares at $18.44 ($604k)
Smith Jeffrey T L, Managing Director
Sold 86.1% of holdings ($701k position)5,272 shares left6.5x usual sizeFiling
- 3 Form 4 sale ZYMEUnusualJan 6, 2025 +1939 days
Sold 11,110 shares at $14.92 ($166k)
Smith Jeffrey T L, EVP & Chief Medical Officer
No 10b5-1 planSold 55.6% of holdings ($298k position)8,890 shares leftFirst sale on recordFollows a Form 144Filing
- 4 Form 144 notice ZYMENoticeJan 6, 2025 same day
Filed to sell 11,110 shares ($161k)
Smith Jeffrey T L, Officer
No 10b5-1 planFirst sale on recordFiling
- 5 Form 4 sale ZYMEUnusualJan 5, 2026 +364 days
Sold 10,538 shares at $25.10 ($265k)
Smith Jeffrey T L, EVP & Chief Medical Officer
No 10b5-1 planSold 36.5% of holdings ($725k position)18,352 shares leftFollows a Form 144Filing
- 6 Form 144 notice ZYMENoticeJan 5, 2026 same day
Filed to sell 10,538 shares ($281k)
Smith Jeffrey T L, Officer
No 10b5-1 planFiling
- 7 Form 4 sale ZYMEUnusualJan 12, 2026 +7 days
Sold 9,310 shares at $22.67 ($211k)
Smith Jeffrey T L, EVP & Chief Medical Officer
No 10b5-1 planSold 25.8% of holdings ($817k position)26,708 shares leftFollows a Form 144Filing
- 8 Form 144 notice ZYMENoticeJan 12, 2026 same day
Filed to sell 9,310 shares ($216k)
Smith Jeffrey T L, Officer
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (35)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Jan 12, 2026 | ZYME | Officer | Form 144 notice | 9,310 | $216k | Notice | SEC | |
| Jan 12, 2026 | Jan 12, 2026 | ZYME | EVP & Chief Medical Officer | Form 4 sale | 9,310 | $211k | 25.8% | Unusual | SEC |
| Jan 5, 2026 | Jan 5, 2026 | ZYME | Officer | Form 144 notice | 10,538 | $281k | Notice | SEC | |
| Jan 5, 2026 | Jan 5, 2026 | ZYME | EVP & Chief Medical Officer | Form 4 sale | 10,538 | $265k | 36.5% | Unusual | SEC |
| Jan 6, 2025 | Jan 6, 2025 | ZYME | Officer | Form 144 notice | 11,110 | $161k | Notice | SEC | |
| Jan 6, 2025 | Jan 6, 2025 | ZYME | EVP & Chief Medical Officer | Form 4 sale | 11,110 | $166k | 55.6% | Unusual | SEC |
| Sep 16, 2019 | Sep 18, 2019 | ALDER BIOPHARMACEUTICALS INC | Managing Director | Form 4 sale | 32,728 | $604k | 86.1% | Unusual | SEC |
| Dec 3, 2018 | Dec 4, 2018 | ALDER BIOPHARMACEUTICALS INC | Managing Director | Form 4 sale | 5,044 | $70k | 85.9% | Unusual | SEC |
| Nov 1, 2018 | Nov 5, 2018 | ALDER BIOPHARMACEUTICALS INC | Managing Director | Form 4 sale | 5,040 | $68k | 85.8% | Unusual | SEC |
| Oct 1, 2018 | Oct 3, 2018 | ALDER BIOPHARMACEUTICALS INC | Managing Director | Form 4 sale | 5,040 | $78k | 85.8% | Unusual | SEC |
| Sep 4, 2018 | Sep 6, 2018 | ALDER BIOPHARMACEUTICALS INC | Managing Director | Form 4 sale | 5,040 | $91k | 85.8% | Unusual | SEC |
| Aug 1, 2018 | Aug 2, 2018 | ALDER BIOPHARMACEUTICALS INC | Managing Director | Form 4 sale | 5,040 | $98k | 85.8% | Unusual | SEC |
| Jul 2, 2018 | Jul 3, 2018 | ALDER BIOPHARMACEUTICALS INC | Managing Director | Form 4 sale | 12,161 | $188k | 93.6% | Unusual | SEC |
| Jun 1, 2018 | Jun 5, 2018 | ALDER BIOPHARMACEUTICALS INC | Managing Director | Form 4 sale | 12,161 | $217k | 93.6% | Unusual | SEC |
| May 16, 2018 | May 18, 2018 | ALDER BIOPHARMACEUTICALS INC | Managing Director | Form 4 sale | 12,161 | $183k | 93.6% | Unusual | SEC |
| Jun 20, 2017 | Jun 22, 2017 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 585 | $12k | 41.3% | Unusual | SEC |
| Dec 1, 2016 | Dec 5, 2016 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,000 | $68k | 78.3% | Unusual | SEC |
| Nov 1, 2016 | Nov 3, 2016 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,000 | $73k | 100.0% | Unusual | SEC |
| Oct 3, 2016 | Oct 5, 2016 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,000 | $93k | 100.0% | Unusual | SEC |
| Sep 1, 2016 | Sep 6, 2016 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,000 | $97k | 100.0% | Unusual | SEC |
| Aug 15, 2016 | Aug 17, 2016 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,000 | $94k | 100.0% | Unusual | SEC |
| Jun 3, 2016 | Jun 7, 2016 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 16,090 | $486k | 100.0% | Unusual | SEC |
| Dec 1, 2015 | Dec 3, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 4,272 | $159k | 100.0% | Unusual | SEC |
| Nov 2, 2015 | Nov 4, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,900 | $131k | 100.0% | Unusual | SEC |
| Oct 1, 2015 | Oct 5, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,900 | $126k | 100.0% | Unusual | SEC |
| Sep 1, 2015 | Sep 3, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,900 | $150k | 100.0% | Unusual | SEC |
| Aug 3, 2015 | Aug 5, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,900 | $178k | 100.0% | Unusual | SEC |
| Jul 1, 2015 | Jul 6, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,900 | $200k | 100.0% | Unusual | SEC |
| Jun 1, 2015 | Jun 3, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,900 | $162k | 100.0% | Unusual | SEC |
| May 22, 2015 | May 26, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 61,818 | $2.4M | 100.0% | Unusual | SEC |
| May 1, 2015 | May 5, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,900 | $100k | 100.0% | Unusual | SEC |
| Apr 1, 2015 | Apr 3, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,900 | $107k | 100.0% | Unusual | SEC |
| Mar 2, 2015 | Mar 4, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,900 | $102k | 100.0% | Unusual | SEC |
| Jan 27, 2015 | Jan 28, 2015 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 3,900 | $109k | 100.0% | Unusual | SEC |
| Nov 24, 2014 | Nov 25, 2014 | ALDER BIOPHARMACEUTICALS INC | Sr. VP Translational Medicine | Form 4 sale | 29,090 | $468k | 100.0% | Unusual | SEC |